Reference
- Ranga Rao, A., Phang, S.M., Sarada, R., Ravishankar, G.A. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications – A review. Mar. Drugs. 2014, 12, 128–152. 2.
- Pashkow, F.J., Watumull, D.G., Campbell, C.L. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008 May 22;101(10A):58D-68D.
- Park JS, Chyun JH, Kim YK, Line LL, Chew BP. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab (Lond). 2010, 7:18.
- Nishida, Y., Yamashita, E., Miki, W. Quenching activities of common hydrophilic and lipophilic antioxidants against singlet oxygen using chemiluminescence detection system. Carotenoid Science, 2007, 11, 16–20.
- Miki, W. Biological functions and activities of animal carotenoids. Pure Appl. Chem. 1(63), 1991, 141–146.
- Naguib, Y.M.A. Antioxidant activities of astaxanthin and related carotenoid. J. Agric. Food Chem. 48, 2000, 1150–1154.
- Lee, S., et al. (2003). “Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IkB Kinase-dependent NFR-kB activation.” Molecules and Cells. 16(1):97-105.
- Choi, SK., et al. (2008). “Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells.” Journal of Microbiology and Biotechnology. 18(12):1990-1996.
- Sakai, S., et al. (2009). “Inhibitory effect of carotenoids on the degranulation of mast cells via suppression of antigen-induced aggregation of high affinity IgE receptors.” The Journal of Biological Chemistry. 284(41):28172-28179.
- Mason, P., et al. (2006). “Refecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity,” Journal of Cardiovascular Pharmacology. 47(1): S7–S14.
- Kidd, P. (2011). “Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential.” Alternative Medicine Review. 16(4):355-364.
- Nagaki Y. et al., Effect of astaxanthin on accommodation and asthenopia. Folia Ophthalomogica Japonica. 2010;3(5):461-68. 6.
- Ekpe, L., Inaku, K., Ekpe, V. Antioxidant effects of astaxanthin in various diseases – A review. J Mol Pathophysiol, 2018, 7(1): 1-6.
- Shimidzu, N., Goto, M., Miki, W. (1996). “Carotenoids as singlet oxygen quenchers in marine organisms.” Fisheries Science. 62(1): 134-137.
- Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1679-85.
- J Pharm Pharmacol. 2008 Oct;60(10):1365-74.
- Ophthalmology 2008 Feb;115(2):324-333.e2.
- Tso, M., Lam, T. (1996) “Method of Retarding and Ameliorating Central Nervous System and Eye Damage.”